Natalizumab

Cat. No.: PI189261107

Description: Natalizumab belongs to the group of monoclonal antibodies. The active substance prevents leukocytes from entering inflammatory foci. It is used for the treatment of multiple sclerosis and Crohn's disease.

Product Details

CAS	189261-10-7
Product Status	Development
Uses	Immunosuppressants drugs
Molecular Size	Large
Controlled Substance	No

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *

For product and service inquiries, please use our online system or send an email to .